Ameriprise’s Sangamo Therapeutics SGMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-75,274
Closed -$27K 3994
2024
Q2
$27K Buy
75,274
+63,800
+556% +$22.9K ﹤0.01% 3835
2024
Q1
$7.69K Sell
11,474
-198,764
-95% -$133K ﹤0.01% 3838
2023
Q4
$114K Buy
210,238
+127,228
+153% +$69.1K ﹤0.01% 3800
2023
Q3
$49.8K Buy
+83,010
New +$49.8K ﹤0.01% 3836
2023
Q2
Sell
-26,437
Closed -$46.5K 3991
2023
Q1
$46.5K Sell
26,437
-42,636
-62% -$75K ﹤0.01% 3870
2022
Q4
$217K Sell
69,073
-12,108
-15% -$38K ﹤0.01% 3685
2022
Q3
$398K Sell
81,181
-3,582
-4% -$17.6K ﹤0.01% 3473
2022
Q2
$351K Buy
84,763
+19,891
+31% +$82.4K ﹤0.01% 3515
2022
Q1
$377K Buy
64,872
+41
+0.1% +$238 ﹤0.01% 3570
2021
Q4
$486K Buy
64,831
+37,656
+139% +$282K ﹤0.01% 3533
2021
Q3
$245K Sell
27,175
-204
-0.7% -$1.84K ﹤0.01% 3651
2021
Q2
$328K Sell
27,379
-46,533
-63% -$557K ﹤0.01% 3601
2021
Q1
$926K Sell
73,912
-66,821
-47% -$837K ﹤0.01% 3174
2020
Q4
$2.2M Sell
140,733
-57,575
-29% -$898K ﹤0.01% 2741
2020
Q3
$1.87M Buy
198,308
+167,607
+546% +$1.58M ﹤0.01% 2700
2020
Q2
$275K Buy
30,701
+12,131
+65% +$109K ﹤0.01% 3391
2020
Q1
$119K Buy
+18,570
New +$119K ﹤0.01% 3518
2018
Q2
Sell
-127,375
Closed -$2.42M 3678
2018
Q1
$2.42M Buy
+127,375
New +$2.42M ﹤0.01% 2619
2014
Q4
Sell
-420
Closed -$5K 4297
2014
Q3
$5K Buy
420
+190
+83% +$2.26K ﹤0.01% 5109
2014
Q2
$4K Buy
230
+40
+21% +$696 ﹤0.01% 4992
2014
Q1
$3K Hold
190
﹤0.01% 4927
2013
Q4
$3K Sell
190
-3,350
-95% -$52.9K ﹤0.01% 4764
2013
Q3
$37K Hold
3,540
﹤0.01% 3994
2013
Q2
$27K Buy
+3,540
New +$27K ﹤0.01% 4092